Major pharmaceutical companies continually research and develop new cancer drugs and treatments, which must be shown to be safe and effective before doctors can prescribe them to patients. Through lymphoma clinical trials, researchers test the effects of new medications on a group of volunteers with lymphoma. Following a strict protocol and using carefully controlled conditions, researchers evaluate the drugs under development and measure the ability of the new drug to treat lymphoma, its safety, and any possible side effects.
Some patients with lymphoma are reluctant to take part in clinical trials for fear of getting no treatment at all for their lymphoma. This is simply not true. Patients with lymphoma who participate in lymphoma clinical trials receive the most effective therapy currently available for their condition -- or they may receive lymphoma treatments that are being evaluated for future use. These lymphoma treatments may be even more effective than currently available lymphoma treatments. The only way to determine if the newer treatment is better than currently available treatments is by clinical trial participation.
The antitumor potential of cartilage has been investigated extensively in laboratory and animal studies. Some of these studies have assessed the toxicity of cartilage products toward cancercellsin vitro.[1,2] Reviewed in [3,4,5,6]
Powdered Cartilage Products
In one study, cells from 22 freshly isolated human tumors (nine ovary, three lung, two brain, two breast, and one each of sarcoma, melanoma, colon, pancreas, cervix, and testis) and three human cultured cell lines (breast cancer, colon...
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service enabling patients to search for cancer trials based on disease and location.